News
-
KLOW Peptide Blend: Four Peptides, One Vial
KLOW combines four peptides — BPC-157, TB-500, GHK-Cu, and KPV — in one compounded vial, each mapped to a different phase of tissue repair.
-
BPC-157 Peptide Therapy: Evidence and Limits
BPC-157 has three decades of animal research behind it, one clinical study in the most recent systematic review, and a regulatory status most websites leave out.
-
BPC-157 vs TB-500: How the Repair Peptides Differ
Two peptides studied for tissue repair, two genuinely different mechanisms — and an evidence base that is still almost entirely preclinical. What separates BPC-157 from TB-500, and what neither has been shown to do yet.
-
Melanotan 2 Side Effects Beyond the Tan
Melanotan II's prospective human trial record is small; broader safety information comes mainly from case reports and seized vials.
-
KPV Peptide and the Gut Inflammation Evidence
KPV is the C-terminal tripeptide of alpha-MSH, and in mice whose MC1R does not function, every animal in the KPV-treated group survived DSS colitis — a result that points away from melanocortin receptors entirely.
-
Tirzepatide vs Semaglutide: The Head-to-Head Data
In the SURMOUNT-5 trial, adults with obesity but without diabetes averaged 20.2% body-weight loss on tirzepatide and 13.7% on semaglutide over 72 weeks.
-
SS-31 Peptide: A Patient's Guide to Elamipretide
SS-31 and elamipretide are two names for the same four-amino-acid peptide, and its branded injectable form received accelerated approval from the FDA on September 19, 2025 for a single ultra-rare genetic disease.
-
What Does Tesamorelin Do?
In a 26-week Phase 3 trial in adults with HIV-associated lipodystrophy, visceral fat fell 10.9% on tesamorelin versus 0.6% on placebo; the pooled Phase 3 analysis reported a 15.4% effect against placebo.
-
CJC-1295 and Ipamorelin: Why They're Paired
One prescription, two receptors: CJC-1295 signals through the GHRH receptor while ipamorelin mimics ghrelin at GHSR-1a — two separate inputs to the same growth-hormone axis.
-
TB-500 for Injury Recovery, Tissue by Tissue
TB-500 is a synthetic fragment of thymosin beta-4. Human studies of the full-length parent also include intravenous Phase 1 safety and pharmacokinetic trials and topical ophthalmic trials, in addition to Phase 2 chronic-wound studies.
-
How Does PT-141 Work? Brain, Not Blood Vessels
PT-141 activates melanocortin receptors; two Phase 3 trials in 1,267 premenopausal women measured desire and distress, not brain circuitry, and the Vyleesi label says its mechanism for improving HSDD is unknown.
-
Tirzepatide Clinical Trials: What the Data Show
Two phase 3 programmes, a cardiovascular outcome trial that reported in December 2025, and more than 18,000 participants — here is what the published evidence actually shows, dose by dose.
-
Thymosin Alpha 1 Peptide: The Trial Record
Thymalfasin — the drug form of the thymosin alpha 1 peptide — is approved in over 30 countries, and the largest trial ever run on it, in 1,106 sepsis patients, returned a 28-day mortality hazard ratio of 0.97.
-
MOTS-c Peptide Benefits: Rodent Depth, Human Hints
MOTS-c is a peptide your mitochondria encode themselves — and it is studied for how cells handle fuel. The rodent evidence runs deep; the human evidence is just beginning.
-
Wolverine Peptide Stack: Two Peptides, One Rx
BPC-157 and TB-500 are usually sold together as the Wolverine peptide stack. This is what the published research measured, what it did not, and how a prescription evaluation works.
-
The DSIP Peptide: A 1970s Sleep Mystery
The DSIP peptide was isolated from the blood of sleeping rabbits in 1970s Switzerland, yet no one has ever found its receptor — or the gene that would prove mammals make it.
-
GHK-Cu Benefits: The Copper Peptide, Explained
GHK-Cu benefits start from one well-documented fact: blood levels of the three-amino-acid peptide GHK fall from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60.
-
Semax Peptide: How It Works in the Brain
How does the Semax peptide work? Most of the mechanism evidence is rodent, the human evidence is intranasal, and the real picture is narrower — and more interesting — than the internet suggests.
-
What Does Kisspeptin Do? The Signal Above GnRH
Kisspeptin sits one rung above GnRH in the reproductive axis, and the ~4-minute half-life routinely quoted for kisspeptin-10 — the form coming soon to Promise — has been measured in people: 3.8 minutes in men, 4.1 in women.
-
A Patient's Guide to NAD+ Injections
NAD+ is a coenzyme found in every living cell, yet most human trial data comes from oral precursors like NR and NMN — including a 2025 meta-analysis in adults with mean ages of 61 to 83 that found no significant muscle benefit.
Page 22 of 23 · 443 articles